Table 3 Total yearly costs for the management of asthma patients in Italy according to different scenarios considered
From: Economic impact of a more extensive use of FENO testing on the Italian population with asthma
Scenarios | SOC | FENO | Cost SOC | Cost FENO | TOTAL IMPACT ON THE NHS | Difference compared to scenario 1 (savings) |
|---|---|---|---|---|---|---|
1 | 100% | 0% | 1,599,217,876 € | 0 € | 1,599,217,876 € | - |
2 | 50% | 50% | 799,608,938 € | 697,514,874 € | 1,497,123,811 € | -102,094,064 € |
3 | 0% | 100% | 0 € | 1,395,029,747 € | 1,395,029,747 € | -204,188,128 € |